On July 27, OPKO Health, Inc. released its Q2 numbers. So, OPK's revenue from transfer of IP and oth

OPKO Health (OPK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b

Investors were also cheered by a substantial narrowing of the company's net loss. Ditto for the rais

OPK beats Q2 estimates as pharmaceutical growth, Nicoya income and lower costs narrow losses and lif

Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se

US stocks trade higher, Dow up 1% on Tuesday. Boeing gains 5% after reporting Q2 results. Kiniksa Ph

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet

Celestica Inc (NYSE: CLS) exceeded analyst estimates with quarterly earnings of $2.54 per share and

OPKO Health, Inc. (OPK) Q2 2026 Earnings Call Transcript

While the top- and bottom-line numbers for OPKO Health (OPK) give a sense of how the business perfor

OPKO Health (OPK) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estim

OPKO Health NASDAQ: OPK reported a narrower second-quarter loss as gains tied to its diagnostics res

Gainers Gossamer Bio (NASDAQ:GOSS) shares rose 28.8% to $0.26 during Monday's after-market sess

OPKO Health (NASDAQ:OPK) raises FY2026 sales outlook from $530.000 million-$560.000 million to $560.

OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.01) per share which beat the analyst conse

MIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated

OPKO Health's growth outlook rests on RAYALDEE, BioReference gains and partnerships, though losses a

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated

Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market

MIAMI, June 15, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) OPKO Biologics, an OPKO Hea

OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?

OPKO Health leans on RAYALDEE and key partnerships, such as BioReference and 4Kscore, as it ramps to

Multispecific antibody conjugated LNP/mRNA platform enables in vivo T-cell engineering and systemic

MIAMI, April 30, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) today announced tha

ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc

OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a sma

Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. P

OPKO Health, Inc. (OPK) Q1 2026 Earnings Call Transcript

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly los

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin

  During Friday's trading, 293 companies set new 52-week lows.

  On Thursday, 241 companies hit new 52-week lows.

  Monday saw 196 companies set new 52-week lows.

  On Monday, 79 companies reached new 52-week lows.

Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings a

  During Wednesday's trading, 517 companies set new 52-week lows.

  On Friday, 404 stocks made new 52-week lows.

  Monday saw 825 companies set new 52-week lows.

  On Thursday, 1076 companies hit new 52-week lows.

  On Tuesday, 507 stocks hit new 52-week lows.